Header Logo

Connection

ERIC ROHREN to Tomography, X-Ray Computed

Back to Details
This is a "connection" page, showing publications ERIC ROHREN has written about Tomography, X-Ray Computed.
ERIC ROHREN
Connection Strength
2.331
Tomography, X-Ray Computed
  1. Spectrum of Benign Bone Conditions on NaF-PET. Semin Nucl Med. 2017 07; 47(4):392-396.
    View in: PubMed
    Score: 0.318
  2. Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study. AJR Am J Roentgenol. 2016 Mar; 206(3):623-31.
    View in: PubMed
    Score: 0.294
  3. Qualitative FDG PET Image Assessment Using Automated Three-Segment MR Attenuation Correction Versus CT Attenuation Correction in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Sep; 205(3):652-8.
    View in: PubMed
    Score: 0.284
  4. PET/Computed Tomography and Patient Outcomes in Melanoma. PET Clin. 2015 Apr; 10(2):243-54.
    View in: PubMed
    Score: 0.274
  5. Implementation of automated tube current modulation in PET/CT: prospective selection of a noise index and retrospective patient analysis to ensure image quality. J Nucl Med Technol. 2011 Jun; 39(2):83-90.
    View in: PubMed
    Score: 0.211
  6. F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review. Clin Nucl Med. 2011 Feb; 36(2):96-100.
    View in: PubMed
    Score: 0.207
  7. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Nov; 205(5):1094-101.
    View in: PubMed
    Score: 0.072
  8. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. J Nucl Med. 2015 Aug; 56(8):1177-84.
    View in: PubMed
    Score: 0.070
  9. Alpha Emitter Radium 223 in High-Risk Osteosarcoma: First Clinical Evidence of Response and Blood-Brain Barrier Penetration. JAMA Oncol. 2015 May; 1(2):253-5.
    View in: PubMed
    Score: 0.069
  10. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2014 May; 41(5):906-14.
    View in: PubMed
    Score: 0.064
  11. (18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging. 2013 Dec; 40(12):1809-16.
    View in: PubMed
    Score: 0.061
  12. Reporting guidance for oncologic 18F-FDG PET/CT imaging. J Nucl Med. 2013 May; 54(5):756-61.
    View in: PubMed
    Score: 0.060
  13. False-positive lesions mimicking breast cancer on FDG PET and PET/CT. AJR Am J Roentgenol. 2012 Mar; 198(3):W304-14.
    View in: PubMed
    Score: 0.056
  14. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1381-6.
    View in: PubMed
    Score: 0.055
  15. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009 Jul 10; 27(20):3303-11.
    View in: PubMed
    Score: 0.046
  16. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med. 2009 Feb; 50(2):231-8.
    View in: PubMed
    Score: 0.045
  17. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med. 2004 Apr; 34(2):134-53.
    View in: PubMed
    Score: 0.032
  18. Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy. Clin Nucl Med. 2016 Apr; 41(4):268-73.
    View in: PubMed
    Score: 0.018
  19. The acetabular fossa hot spot on 18F-FDG PET/CT: epidemiology, natural history, and proposed etiology. Skeletal Radiol. 2015 Jan; 44(1):107-14.
    View in: PubMed
    Score: 0.017
  20. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012 Apr; 198(4):902-8.
    View in: PubMed
    Score: 0.014
  21. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012 Apr; 10(4):449-54.
    View in: PubMed
    Score: 0.014
  22. Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res. 2011 Sep 15; 17(18):6052-60.
    View in: PubMed
    Score: 0.013
  23. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44.
    View in: PubMed
    Score: 0.012
  24. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009 Jun; 10(6):606-14.
    View in: PubMed
    Score: 0.012
  25. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009 Mar; 50(3):340-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.